Flu vaccine delays 'likely' in no-deal Brexit

Doctors have warned that a no-deal Brexit makes it very ‘likely’ that there will be a delay in flu vaccine supply this year.

Major flu vaccine manufacturer Sanofi said delays in deciding what strains of flu to use in the vaccine mean over a million doses will have to be imported after 31 October. Therefore, NHS leaders warn that the EU departure date coincides with the winter season in a way that creates ‘a perfect storm for the NHS’.

The doses - which represent about 20 per cent of imported flu vaccines - are specifically intended for under-65s in at risk groups, as well as healthcare professionals, who are routinely exposed to the virus.

Andrew Goddard, president of the Royal College of Physicians, told Newsnight: “What we can see is we're likely to not have enough flu vaccine, we are likely not to have the flu vaccine coverage that we've had in previous years, and that is likely to have an impact on the NHS.”

Event Diary

This story was first published in digitalhealth.net

Supplier Profiles

CDC success at Victoria Infirmary, Northwich creates ideal model for future patient pathway reforms

Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients

Gain valuable insight with Adveco for gas to electric decarbonisation projects

Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho